IL1B and Schnitzler syndrome: At further follow-up, the patient did not require any steroid therapy: the inflammatory process (represented by the presence of MGUS and elevated amyloid levels) induced over the 17 months by recurrent SAT as well as Schnitzler syndrome finally subsided thanks to the IL-1 antagonist treatment.